[Medical treatment of depression during pregnancy and breastfeeding].
Medical treatment of depression during pregnancy and breastfeeding often involves concern by both the patient and the doctor because of the fear of adverse reactions or malformations of the child. This article gives an updated review on how antidepressants, lithium, antipsychotics and ECT can be used during pregnancy and breastfeeding, and presents a treatment algorithm which is used at Odense University Hospital.
Nielsen
Rene Ernst
RE
Odense Universitetshospital, Psykiatrisk Afdeling, Odense C. kurt.b.stage@dadlnet.dk
Stage
Kurt Bjerregaard
KB
Christensen
Palle Mark
PM
Mortensen
Sven
S
Andersen
Lise Lotte Torvin
LL
Damkier
Per
P
D000014:Abnormalities, Drug-Induced / Q000209:etiology; D018687:Antidepressive Agents, Second-Generation / Q000009:adverse effects / Q000627:therapeutic use*; D000929:Antidepressive Agents, Tricyclic / Q000009:adverse effects / Q000627:therapeutic use; D001942:Breast Feeding; D003863:Depression / Q000188:drug therapy*; D019052:Depression, Postpartum / Q000188:drug therapy*; D003866:Depressive Disorder / Q000188:drug therapy*; D005260:Female; D006801:Humans; D018020:Lithium Compounds / Q000009:adverse effects / Q000627:therapeutic use; D008431:Maternal-Fetal Exchange; D008895:Milk, Human / Q000737:chemistry; D011247:Pregnancy; D011248:Pregnancy Complications / Q000188:drug therapy*; D012307:Risk Factors; D017367:Selective Serotonin Reuptake Inhibitors / Q000009:adverse effects / Q000627:therapeutic use*
D018687:Antidepressive Agents, Second-Generation; D000929:Antidepressive Agents, Tricyclic; D018020:Lithium Compounds; D017367:Selective Serotonin Reuptake Inhibitors